Risankizumab On-Body Injector (OBI) clinical trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

This study looks at a new medicine called risankizumab for Crohn's disease. We're checking how well it works and if it's safe for people who have already started treatment. It's like a follow-up to see how different doses work and how people feel over time.